Alpha Teknova, Inc. Common Stock (TKNO) is a publicly traded Healthcare sector company. As of May 21, 2026, TKNO trades at $4.20 with a market cap of $194.08M and a P/E ratio of -11.33. TKNO moved -2.15% today. Year to date, TKNO is -7.50%; over the trailing twelve months it is -44.94%. Its 52-week range spans $1.91 to $10.37. Analyst consensus is buy with an average price target of $9.50. Rallies surfaces TKNO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TKNO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TKNO recently traded at $4.20. Market cap is $194.08M. P/E ratio is -11.33. Revenue is $41.80M.
| Metric | Value |
|---|---|
| Price | $4.20 |
| Market Cap | $194.08M |
| P/E Ratio | -11.33 |
| EPS | $-0.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.37 |
| 52-Week Low | $1.91 |
| Volume | 3.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $41.80M |
| Net Income | $-17.17M |
| Gross Margin | 34.01% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $40.52M | $-17.26M | $-0.32 |
| 2024 | $37.74M | $-26.75M | $-0.57 |
| 2023 | $36.68M | $-36.78M | $-1.16 |
| 2022 | $41.42M | $-47.47M | $-1.69 |
5 analysts cover TKNO: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.50.